| Withdrawn | A Study of [F-18]HX4 (PET Imaging)Evaluated in Head and Neck Cancer Patients Head and Neck Cancer | Phase 1 / Phase 2 | 2012-09-01 |
| Terminated | [F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis Carotid Stenosis | Phase 2 | 2012-05-01 |
| Terminated | Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects Breast Cancer | Phase 1 | 2011-05-01 |
| Completed | Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors Head and Neck Cancer, Lung Cancer, Liver Cancer | Phase 2 | 2010-02-01 |
| Completed | Efficacy Study of [F-18]RGD-K5 Positron Emission Tomography (PET) as a Tool to Monitor Response to an Anti-ang Metastatic Breast Cancer, Metastatic Colon/Rectum Cancer, Non-squamous Non-small Cell Lung Cancer | Phase 2 | 2009-09-01 |
| Completed | Exploratory and Safety Study of [F-18]W372 Alzheimer's Disease | EARLY_Phase 1 | 2009-08-01 |
| Completed | Clinical Evaluation of the New Hypoxia Imaging Agent HX4 Head and Neck Cancer, Lung Cancer, Liver Cancer | Phase 1 / Phase 2 | 2009-06-01 |
| Completed | An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037 Lung Cancer, Squamous Cell Carcinoma, Head and Neck Cancer | EARLY_Phase 1 | 2009-04-01 |
| Completed | A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation Lung Cancer, Head and Neck Cancer | N/A | 2009-02-01 |
| Completed | Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5 Sarcoma, Melanoma, Lung Cancer | EARLY_Phase 1 | 2008-08-01 |
| Completed | An Exploratory, Open Label, Single Center Study of [F-18]HX4 Head and Neck Cancer | EARLY_Phase 1 | 2008-01-01 |
| Completed | Phase I, Open Label, Single Center Safety Study of [F-18]FLT Brain Cancer | Phase 1 | 2007-11-01 |